Amgen To Appeal CHMP Opinion On Vectibix(R) (Panitumumab) Use With Chemotherapy In Metastatic Colorectal Cancer In Europe
THOUSAND OAKS, California, March 30, 2011 /PRNewswire/ -- Amgen announced today that it has submitted a request to the European Medicines Agency (EMA) for a re-examination of the negative opinion…